The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Clopidogrel and Prasugrel
Paul A. Gurbel(Sinai Hospital), Brian Baker, Douglas Logan(Medpace (United States)), Thomas D. Nolin(Yamaha (Japan)), Dominick J. Angiolillo(University of Florida), William L. Bailey(Daiichi Sankyo (United States)), Young‐Hoon Jeong(Chung-Ang University Hospital), Kenneth C. Lasseter, Dean J. Kereiakes(Health Net), Kevin P. Bliden(Sinai Hospital), Clement K. Ojeh(Eli Lilly (United States)), Jen‐Fue Maa(Daiichi Sankyo (United States)), Alex E. White, Joseph A. Jakubowski(Indiana Biosciences Research Institute), Udaya S. Tantry(Sinai Hospital)
Cited by 139
Related Papers
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis
|The Lancet|2016|1k
A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
|New England Journal of Medicine|1987|945
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention
|Circulation|2007|882
Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement
|New England Journal of Medicine|2020|832